Raras
Buscar doenças, sintomas, genes...
Displasia pseudorreumatoide progressiva
ORPHA:1159CID-10 · Q77.7CID-11 · LD24.3OMIM 208230DOENÇA RARA

A artropatia pseudorreumatóide progressiva (displasia) da infância (PPAC; PPD) apresenta-se como displasia espondiloepifisária (SED) tardia com artropatia progressiva e é descrita como um subtipo autossômico recessivo específico de SED.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A artropatia pseudorreumatóide progressiva (displasia) da infância (PPAC; PPD) apresenta-se como displasia espondiloepifisária (SED) tardia com artropatia progressiva e é descrita como um subtipo autossômico recessivo específico de SED.

Pesquisas ativas
1 ensaio
1 total registrados no ClinicalTrials.gov
Publicações científicas
110 artigos
Último publicado: 1993

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Childhood
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q77.7
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
34 sintomas
💪
Músculos
2 sintomas

+ 23 sintomas em outras categorias

Características mais comuns

90%prev.
Pequenas articulações da mão estreitas
Muito frequente (99-80%)
90%prev.
Artropatia poliarticular
Muito frequente (99-80%)
90%prev.
Marcha anserina
Muito frequente (99-80%)
90%prev.
Platispondilia
Muito frequente (99-80%)
90%prev.
Inchaço articular
Muito frequente (99-80%)
90%prev.
Placas terminais vertebrais irregulares
Muito frequente (99-80%)
59sintomas
Muito frequente (7)
Frequente (18)
Ocasional (17)
Muito raro (3)
Sem dados (14)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 59 características clínicas mais associadas, ordenadas por frequência.

Pequenas articulações da mão estreitasNarrow small joints of the hand
Muito frequente (99-80%)90%
Artropatia poliarticularPolyarticular arthropathy
Muito frequente (99-80%)90%
Marcha anserinaWaddling gait
Muito frequente (99-80%)90%
PlatispondiliaPlatyspondyly
Muito frequente (99-80%)90%
Inchaço articularJoint swelling
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico110PubMed
Últimos 10 anos75publicações
Pico202110 papers
Linha do tempo
2026Hoje · 2026📈 2021Ano de pico🧪 2025Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

CCN6Cellular communication network factor 6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in mitochondrial electron transport and mitochondrial respiration (PubMed:27252383). Through its regulation of the mitochondrial function may play a role in normal postnatal skeletal growth and cartilage homeostasis (PubMed:10471507, PubMed:27252383)

LOCALIZAÇÃO

SecretedMitochondrion

MECANISMO DE DOENÇA

Progressive pseudorheumatoid dysplasia

An autosomal recessive disorder characterized by stiffness and swelling of joints, motor weakness and joint contractures. Signs and symptoms of the disease develop typically between three and eight years of age. This progressive disease is a primary disorder of articular cartilage with continued cartilage loss and destructive bone changes with aging.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
progressive pseudorheumatoid arthropathy of childhood
HGNC:12771UniProt:O95389

Variantes genéticas (ClinVar)

96 variantes patogênicas registradas no ClinVar.

🧬 CCN6: NM_198239.2(CCN6):c.783+1_783+6del ()
🧬 CCN6: NM_198239.2(CCN6):c.94_95del (p.Glu32fs) ()
🧬 CCN6: NM_198239.2(CCN6):c.680dup (p.Ser228fs) ()
🧬 CCN6: NM_198239.2(CCN6):c.589+2T>C ()
🧬 CCN6: NM_198239.2(CCN6):c.510_511del (p.Gly171fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 61 variantes classificadas pelo ClinVar.

58
3
Patogênica (95.1%)
VUS (4.9%)
VARIANTES MAIS SIGNIFICATIVAS
CCN6: NM_198239.2(CCN6):c.76_83del (p.Pro26fs) [Likely pathogenic]
CCN6: NM_198239.2(CCN6):c.298T>A (p.Cys100Ser) [Likely pathogenic]
CCN6: NM_198239.2(CCN6):c.667T>C (p.Cys223Arg) [Likely pathogenic]
CCN6: NM_198239.2(CCN6):c.348C>A (p.Tyr116Ter) [Likely pathogenic]
CCN6: NM_198239.2(CCN6):c.737T>C (p.Leu246Pro) [Likely pathogenic]

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Displasia pseudorreumatoide progressiva

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

1 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥇Melhor nível de evidência: Meta-análise
Timeline de publicações
75 papers (10 anos)
#1

Identification and functional analysis of CCN6 variants in progressive pseudorheumatoid dysplasia: Exploring the potential role of ferroptosis and apoptosis in chondrocytes.

Genes &amp; diseases2026 Jan
#2

When it's not juvenile idiopathic arthritis: unmasking monogenic mimickers in children monogenic mimickers of chronic arthritis.

European journal of pediatrics2025 Nov 25

Chronic arthritis in children is widely associated with juvenile idiopathic arthritis (JIA); however, several rare monogenic disorders may mimic its clinical presentation. Misdiagnosis can result in unnecessary immunosuppressive treatment and delay appropriate care. This study aimed to share our experience with monogenic disorders presenting as chronic arthritis and highlight their distinguishing clinical and imaging features. This retrospective cohort study included patients initially suspected of having JIA who were later diagnosed with a monogenic disorder. Clinical, laboratory, imaging, and genetic data were also collected and evaluated. Among the 25 patients, the most frequent diagnoses were progressive pseudorheumatoid dysplasia (PPRD; n = 12) and camptodactyly arthropathy-coxa vara-pericarditis (CACP) syndrome (n = 8). Other diagnoses included mucolipidosis type III gamma, primary hypertrophic osteoarthropathy (PHO), and multicentric carpotarsal osteolysis (MCTO). While all PPRD and CACP patients had biallelic pathogenic variants in CCN6 and PRG4, respectively, PHO and MCTO were associated with monoallelic mutations. Common misdiagnoses included polyarticular JIA, leading to the inappropriate use of methotrexate or biologic agents. Several monogenic disorders can mimic JIA in pediatric patients, leading to diagnostic challenges. Clinical features, such as camptodactyly, skeletal deformities, digital clubbing, median nerve neuropathy, and poor response to treatment should prompt further evaluation, including genetic testing. Increased awareness and early recognition of these conditions are crucial to avoid unnecessary immunosuppression and improve patient outcomes. • Several rare monogenic disorders can clinically mimic JIA and misdiagnosis of these monogenic mimickers may lead to inappropriate immunosuppressive treatment and delayed appropriate care. • This study presents a real-world single-center data that systematically characterizes five distinct monogenic disorders mimicking JIA. • Findings emphasize the importance of early suspicion, especially in cases with symmetrical interphalangeal involvement (PPRD), camptodactyly with hip deformity (CACP), or osteolysis with renal/facial anomalies (MCTO), to avoid unnecessary immunosuppression.

#3

Molecular Consequences of CCN6 Variants Encoding WISP3 in Progressive Pseudorheumatoid Dysplasia.

International journal of molecular sciences2025 Sep 11

Progressive pseudorheumatoid dysplasia (PPD) is a rare autosomal recessive cartilage disorder caused by biallelic variants in CCN6, which encodes the matricellular protein WISP3. Although WISP3 is thought to contribute to extracellular matrix (ECM) homeostasis, its precise molecular role in PPD remains unclear. To elucidate how disease-associated CCN6 variants affect chondrocyte function, we overexpressed four variants-p.Cys52*, p.Tyr109*, p.Gly83Glu, and p.Cys114Trp-all located within the IGFBP domain, and evaluated their impact on parameters including redox balance, ER stress, ECM remodeling, gene expression, and protein-protein interactions. The p.Cys52* variant resulted in rapid degradation of WISP3, indicating a complete loss-of-function. The p.Tyr109* variant disrupted ECM regulation, markedly reducing protein interaction capacity, which was correlated with elevated mitochondrial ROS (mtROS) levels and triggered a strong response that led to programmed cell death. Although both missense variants yielded full-length proteins, their effects diverged significantly: p.Gly83Glu induced minor cellular alterations, whereas p.Cys114Trp caused severe protein destabilization, increased ROS accumulation, and high levels of ER stress. Proteomic analysis revealed that p.Cys114Trp acquired novel interaction partners, suggesting a potential gain-of-function mechanism. Collectively, these findings demonstrate that the functional consequences of CCN6 variants depend not only on variant type or domain location but also on their positional and structural context. The distinct cellular responses elicited by each variant underscore the importance of functional validation in modeling PPD pathogenesis and offer valuable biological and therapeutic perspectives.

#4

[Clinical phenotype and genetic analysis of a patient with Progressive pseudorheumatoid dysplasia due to compound heterozygous variants of CCN6 gene and a literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics2025 Sep 10

To explore the clinical phenotype and genetic characteristics of a patient with Progressive pseudorheumatoid dysplasia (PPRD) due to compound heterozygous variants of CCN6 gene. A patient who was admitted to Qilu Hospital of Shandong University due to "bilateral finger joint deformity, bilateral hip and knee joint movement limitation for 19 years" was selected as the study subject. Clinical data of the patient were retrospectively collected. Peripheral blood samples were collected from the patient and her parents and subjected to whole exome sequencing (WES). Long-read sequencing (LRS) and Sanger sequencing were used to verify the candidate variants. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), the pathogenicity of candidate variants was classified. This study was approved by the Medical Ethics Committee of Qilu Hospital of Shandong University (Ethics No.: KYLL-202502 061). The patient, a 23-year-old female, presented with progressive polyarticular deformity, limited movement and abnormal growth and development since childhood. She was initially misdiagnosed as Ankylosing spondylitis and had poor response to sulphasalazine and etoricoxib treatment. WES revealed that she has harbored two heterozygous variants of the CCN6 gene (NM_198239.2), namely c.348C>A and c.676G>C. LRS confirmed that the two variants are located on two homologous chromosomes and constitute compound heterozygous variants. Based on the ACMG guidelines, both variants were rated as pathogenic (PVS1+PM2_Supporting+PM3; PM1+PM2_Supporting+PM3_Supporting+PM5+PP3_Strong). The c.676G>C variant has not been recorded by the HGMD and ClinVar databases. The c.348C>A and c.676G>C compound heterozygous variants of the CCN6 gene probably underlay the pathogenesis of PPRD in this patient. Above finding has enriched the mutational spectrum of PPRD and provided a basis for the clinical diagnosis and genetic counseling.

#5

Progressive Pseudorheumatoid Dysplasia Misdiagnosed as Juvenile Idiopathic Arthritis: Advanced Joint Destruction.

Cureus2025 Sep

Progressive pseudorheumatoid dysplasia (PPRD) is a rare autosomal recessive arthropathy often misdiagnosed as juvenile idiopathic arthritis (JIA). We present the case of a 52-year-old woman with polyarthralgia since age 7, initially diagnosed with seronegative polyarticular JIA and treated with methotrexate at doses ranging from 10 to 15 mg weekly for over two decades, despite the absence of clinical improvement. The rationale for prolonged use was the persistence of joint symptoms under the initial diagnosis of JIA, leading clinicians to continue disease-modifying therapy. Clinical examination revealed joint deformities, limited range of motion, short stature, and limb length discrepancy. Radiographs showed characteristic PPRD features, including flattening of the metacarpophalangeal joints, brachymetatarsia, vertebral fractures, and lumbar osteopenia. Pelvic imaging demonstrated bilateral hip prostheses with loosening of the right prosthesis, superior migration of the femoral component, and screw fracture. Laboratory tests revealed normal inflammatory markers and negative rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies. This case highlights the diagnostic challenges of PPRD and the potential for irreversible joint destruction when diagnosis is delayed. Clinicians should suspect PPRD in early onset polyarthritis with non-inflammatory joint involvement and negative immunologic tests to avoid unnecessary immunosuppressive therapy and initiate timely supportive management.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC94 artigos no totalmostrando 74

2025

When it's not juvenile idiopathic arthritis: unmasking monogenic mimickers in children monogenic mimickers of chronic arthritis.

European journal of pediatrics
2026

Identification and functional analysis of CCN6 variants in progressive pseudorheumatoid dysplasia: Exploring the potential role of ferroptosis and apoptosis in chondrocytes.

Genes &amp; diseases
2025

[Clinical phenotype and genetic analysis of a patient with Progressive pseudorheumatoid dysplasia due to compound heterozygous variants of CCN6 gene and a literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

Progressive Pseudorheumatoid Dysplasia Misdiagnosed as Juvenile Idiopathic Arthritis: Advanced Joint Destruction.

Cureus
2025

Molecular Consequences of CCN6 Variants Encoding WISP3 in Progressive Pseudorheumatoid Dysplasia.

International journal of molecular sciences
2025

Treatment With Romosozumab In Progressive Pseudorheumatoid Dysplasia.

JCEM case reports
2025

Could scoliosis at the age of 7 months be a manifestation of progressive pseudorheumatoid dysplasia? A case report.

Journal of medical case reports
2025

Genetic Diseases Mimicking Rheumatic Disorders: Insights From Southeastern Turkey.

American journal of medical genetics. Part A
2025

From childhood to adulthood: The long-term impact of progressive pseudorheumatoid dysplasia.

Joint bone spine
2025

Case Report: A Novel CCN6 Compound Heterozygous Mutation in Progressive Pseudorheumatoid Dysplasia.

International journal of rheumatic diseases
2024

Proximal Tibial Fracture in Pseudo-Rheumatoid Synovial Chondromatosis: A Case Study.

Journal of orthopaedic case reports
2024

Progressive pseudorheumatoid dysplasia involving a novel CCN6 mutation: a case report.

Frontiers in immunology
2024

First copy number variant in trans with single nucleotide variant in CCN6 causing progressive pseudorheumatoid dysplasia revealed by genome sequencing and deep phenotyping in monozygotic twins.

American journal of medical genetics. Part A
2024

[Bilateral total hip arthroplasty in a 15-year-old patient with progressive pseudorheumatoid dysplasia. Case report and literature review].

Acta ortopedica mexicana
2024

Multiple Joint Replacements for Progressive Pseudorheumatoid Dysplasia: A Case Report.

Journal of orthopaedic case reports
2023

Case 316: Progressive Pseudorheumatoid Dysplasia.

Radiology
2023

Progressive pseudorheumatoid dysplasia involving a novel WISP3 mutation and sacroiliac and hip arthritis: A case report and literature review.

Medicine
2023

Clinical and molecular characterization in a cohort of patients with progressive pseudorheumatoid dysplasia.

American journal of medical genetics. Part A
2023

A novel WISP3 mutation in a Chinese patient with progressive pseudorheumatoid dysplasia.

QJM : monthly journal of the Association of Physicians
2023

Unique mutation spectrum of progressive pseudorheumatoid dysplasia in the Chinese population: a retrospective genotype-phenotype analysis of 105 patients.

World journal of pediatrics : WJP
2022

Gait Alterations in Two Young Siblings with Progressive Pseudorheumatoid Dysplasia.

Children (Basel, Switzerland)
2022

A Rare Skeletal Dysplasia-Close Mimicker Of Juvenile Idiopathic Arthritis-Progressive Pseudorheumatoid Dysplasia.

Journal of Ayub Medical College, Abbottabad : JAMC
2022

Multiple disc herniation in spondyloepiphyseal dysplasia tarda: A rare case report and review of the literature.

BMC musculoskeletal disorders
2022

The genetics of progressive pseudorheumatoid dysplasia.

QJM : monthly journal of the Association of Physicians
2022

Mesenchymal stromal cells from a progressive pseudorheumatoid dysplasia patient show altered osteogenic differentiation.

European journal of medical research
2022

The genetics of progressive pseudorheumatoid dysplasia (PPRD).

QJM : monthly journal of the Association of Physicians
2022

A novel compound heterozygous mutation of WISP3 in progressive pseudorheumatoid dysplasia mimicking juvenile idiopathic arthritis.

QJM : monthly journal of the Association of Physicians
2021

The rare reason of pain in hip girdle: Mucolipidosis type 3 gamma.

The Turkish journal of pediatrics
2022

Specific early signs and long-term follow-up findings of progressive pseudorheumatoid dysplasia (PPRD) in the Turkish cohort.

Rheumatology (Oxford, England)
2021

Progressive pseudorheumatoid dysplasia misdiagnosed as juvenile idiopathic arthritis: a case report.

Journal of medical case reports
2024

Progressive Pseudorheumatoid Dysplasia of Childhood (PPRD)-A Case Series with Recurrent c.740_741del Variant.

Journal of pediatric genetics
2022

A retrospective study of nine patients with progressive pseudorheumatoid dysplasia: to explore early diagnosis and further treatment.

Clinical rheumatology
2021

Case Report: Recurrent Variant c.298 TA in CCN6 Gene Found in Progressive Pseudorheumatoid Dysplasia Patients From Patni Community of Gujarat: A Report of Three Cases.

Frontiers in genetics
2021

Progressive pseudorheumatoid dysplasia: a case series report.

Translational pediatrics
2021

Progressive pseudorheumatoid dysplasia: A rare entity mimicking juvenile idiopathic arthritis.

Clinical case reports
2021

Reconstruction of anatomy and care provisioning in a severe case of spondyloepiphyseal dysplasia.

International journal of paleopathology
2021

Progressive Pseudorheumatoid Dysplasia-Radiographic Evolution Over Twenty Years.

Arthritis &amp; rheumatology (Hoboken, N.J.)
2021

Genetic disorders with symptoms mimicking rheumatologic diseases: A single-center retrospective study.

European journal of medical genetics
2021

Ccn6 Is Required for Mitochondrial Integrity and Skeletal Muscle Function in Zebrafish.

Frontiers in cell and developmental biology
2020

Coexistence of a novel WISP3 pathogenic variant and an MEFV mutation in an Arabic family with progressive pseudorheumatoid dysplasia mimicking polyarticular juvenile idiopathic arthritis.

Pediatric rheumatology online journal
2020

Novel homozygous variant in WISP3 in a family with unrecognized progressive pseudorheumatoid dysplasia.

Clinical case reports
2020

Spondyloepiphyseal dysplasia type Stanescu: Expanding the clinical and molecular spectrum of a very rare type II collagenopathy.

American journal of medical genetics. Part A
2020

Delayed-onset progressive pseudorheumatoid dysplasia with secondary synovial chondromatosis.

BMJ case reports
2020

CCN6 mutation detection in Chinese patients with progressive pseudo-rheumatoid dysplasia and identification of four novel mutations.

Molecular genetics &amp; genomic medicine
2020

Multi-scale mechanical investigation of articular cartilage suffered progressive pseudorheumatoid dysplasia.

Clinical biomechanics (Bristol, Avon)
2021

Mid-Term Outcome of Total Hip Arthroplasty in Patients With Progressive Pseudorheumatoid Dysplasia.

Journal of clinical rheumatology : practical reports on rheumatic &amp; musculoskeletal diseases
2019

Progressive pseudorheumotoid dysplasia: A presentation of four cases with slow and rapid progression and effects of early rehabilitation program.

Turkish journal of physical medicine and rehabilitation
2019

A Novel Homozygous Frameshift Mutation in CCN6 Causing Progressive Pseudorheumatoid Dysplasia (PPRD) in a Consanguineous Yemeni Family.

Frontiers in pediatrics
2020

High Circulating Levels of IL-4 and IL-10 in Progressive Pseudorheumatoid Dysplasia Patient.

Journal of clinical rheumatology : practical reports on rheumatic &amp; musculoskeletal diseases
2019

Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature.

BMC medical genetics
2019

Progressive pseudorheumatoid dysplasia: a report of three cases and a review of radiographic and magnetic resonance imaging findings.

Skeletal radiology
2019

Progressive pseudorheumatoid dysplasia confirmed by whole-exon sequencing in a Chinese adult before corrective surgery.

Journal of orthopaedic surgery and research
2018

[Progressive pseudorheumatoid dysplasia misdiagnosed as ankylosing spondylitis: a case report].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
2019

Progressive pseudorheumatoid dysplasia: a rare childhood disease.

Rheumatology international
2018

Progressive pseudorheumatoid dysplasia with new-found gene mutation of Wntl inducible signaling pathway protein 3.

Pediatric rheumatology online journal
2018

Ilizarov technique in an adolescent patient with progressive pseudorheumatoid dysplasia: A case report.

Medicine
2018

Association analysis on polymorphisms in WISP3 gene and developmental dysplasia of the hip in Han Chinese population: A case-control study.

Gene
2018

Late diagnosis of a truncating WISP3 mutation entails a severe phenotype of progressive pseudorheumatoid dysplasia.

Cold Spring Harbor molecular case studies
2017

Delayed-onset of progressive pseudorheumatoid dysplasia in a Chinese adult with a novel compound WISP3 mutation: a case report.

BMC medical genetics
2018

WISP3 mutation associated with pseudorheumatoid dysplasia.

Cold Spring Harbor molecular case studies
2017

Progressive Pseudorheumatoid Dysplasia or JIA?

Case reports in rheumatology
2016

Novel WISP3 mutations causing progressive pseudorheumatoid dysplasia in two Chinese families.

Human genome variation
2016

Progressive Pseudorheumatoid Dysplasia Misdiagnosed as Seronegative Juvenile Idiopathic Arthritis.

Ethiopian journal of health sciences
2016

WISP3 mutational analysis in Indian patients diagnosed with progressive pseudorheumatoid dysplasia and report of a novel mutation at p.Y198.

Bone &amp; joint research
2016

Whole Exome Screening Identifies Novel and Recurrent WISP3 Mutations Causing Progressive Pseudorheumatoid Dysplasia in Jammu and Kashmir-India.

Scientific reports
2016

An Unusual Coexistence of Progressive Pseudorheumatoid Dysplasia and Relapsing Polychondritis.

Archives of rheumatology
2016

Early severe scoliosis in a patient with atypical progressive pseudorheumatoid dysplasia (PPD): Identification of two WISP3 mutations, one previously unreported.

American journal of medical genetics. Part A
2016

Progressive pseudorheumatoid dysplasia: a close mimicker of juvenile idiopathic arthritis.

BMJ case reports
2016

Biomechanics of walking in adolescents with progressive pseudorheumatoid arthropathy of childhood leads to physical activity recommendations as therapeutic focus.

Clinical biomechanics (Bristol, Avon)
2015

Progressive Pseudorheumatoid Dysplasia With Delayed Diagnosis.

Journal of clinical rheumatology : practical reports on rheumatic &amp; musculoskeletal diseases
2015

Novel COL2A1 variant (c.619G>A, p.Gly207Arg) manifesting as a phenotype similar to progressive pseudorheumatoid dysplasia and spondyloepiphyseal dysplasia, Stanescu type.

Human mutation
2015

A novel compound WISP3 mutation in a Chinese family with progressive pseudorheumatoid dysplasia.

Gene
2015

Identification of a mutation in the WISP3 gene in three unrelated families with progressive pseudorheumatoid dysplasia.

Molecular medicine reports
2015

A homozygous deletion of exon 1 in WISP3 causes progressive pseudorheumatoid dysplasia in two siblings.

Human genome variation
Ver todos os 94 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Displasia pseudorreumatoide progressiva.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Displasia pseudorreumatoide progressiva

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Identification and functional analysis of CCN6 variants in progressive pseudorheumatoid dysplasia: Exploring the potential role of ferroptosis and apoptosis in chondrocytes.
    Genes &amp; diseases· 2026· PMID 41262529mais citado
  2. When it's not juvenile idiopathic arthritis: unmasking monogenic mimickers in children monogenic mimickers of chronic arthritis.
    European journal of pediatrics· 2025· PMID 41288813mais citado
  3. Molecular Consequences of CCN6 Variants Encoding WISP3 in Progressive Pseudorheumatoid Dysplasia.
    International journal of molecular sciences· 2025· PMID 41009407mais citado
  4. [Clinical phenotype and genetic analysis of a patient with Progressive pseudorheumatoid dysplasia due to compound heterozygous variants of CCN6 gene and a literature review].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics· 2025· PMID 41230593mais citado
  5. Progressive Pseudorheumatoid Dysplasia Misdiagnosed as Juvenile Idiopathic Arthritis: Advanced Joint Destruction.
    Cureus· 2025· PMID 41111737mais citado
  6. Progressive Pseudorheumatoid Dysplasia.
    · 1993· PMID 26610319recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:1159(Orphanet)
  2. OMIM OMIM:208230(OMIM)
  3. MONDO:0008827(MONDO)
  4. GARD:9184(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q11825217(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Displasia pseudorreumatoide progressiva
Compêndio · Raras BR

Displasia pseudorreumatoide progressiva

ORPHA:1159 · MONDO:0008827
Prevalência
1-9 / 1 000 000
Herança
Autosomal recessive
CID-10
Q77.7 · Displasia espondiloepifisária
CID-11
Ensaios
1 ativos
Início
Childhood
Prevalência
0.0 (Europe)
MedGen
UMLS
C0432215
EuropePMC
Wikidata
Papers 10a
Evidência
🥇 Meta-análise
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades